Skip to main content
. 2016 Sep 22;7(9):e2376. doi: 10.1038/cddis.2016.195

Figure 5.

Figure 5

Compound 12 inhibition of Hh-dependent MB tumor cell growth. (ac) Ex vivo cell cultures from Ptch1+/− mice MBs were treated with compound 12, Cyclopamine, Vismodegib, LDE-225 or DMSO only. (a and b) After the indicated times, a trypan blue count was performed to determine the growth rate of viable cells. (c) Gli1 mRNA expression levels were determined by qRT-PCR normalized to endogenous control (β2-microglobulin and HPRT). (df) Compound 12 inhibits MB-SCs self-renewal. (d) Suspension of single MB-SCs isolated from Ptch1+/− mice were cultured in stem cell medium to allow the formation of primary neurospheres. Primary neurospheres were dissociated and treated with increasing concentrations of compound 12, Cyclopamine or DMSO only. After 7 days of treatment, the number of secondary neurospheres derived from a known number of single cells was counted. The self-renewal MB-SCs' capability is expressed as percentage of neurosphere-forming cells. (e) Representative bright-field images of tumor neurospheres after compound 12 or Cyclopamine treatment are also shown. (f) MB-SCs isolated from Ptch1+/− mice MBs were treated for 48 h with compound 12 or DMSO only. qRT-PCR analysis show Hh, proliferation and stemness target mRNA. For qRT-PCR, results were normalized to endogenous control (β2-microglobulin and HPRT). All data show the mean±S.D. of three independent experiments. *P<0.05; **P<0.01 versus DMSO (CTR)